Studies on the synthesis of polyoxometalates containing sulfanilamide and their inhibition to prostate cancer cell PC-3M

Liu Xia,Zhao Jun,Feng Chang-Gen
DOI: https://doi.org/10.3321/j.issn:0567-7351.2006.19.008
2006-01-01
Acta Chimica Sinica
Abstract:Two new polyoxometalates namely (C6H9N2O2S)(5)HP2Mo18O62 center dot 15H(2)O (SPOM-1) and (C6H9N2O2S)center dot H8P2Mo15V3O62 center dot 8H(2)O (SPOM-2) containing sulfanilamide were synthesized and structurally characterized by elementary analysis and IR spectra. The antitumor activities of these compounds had been investigated in human androgen independent prostate cancer cell PC-3M. SPOM-1 and SPOM-2 were shown to inhibit prostate cancer cell PC-3M significantly, and there was a certain dose-effect relationship. EC50 for the two samples was 38 and 11 mu g center dot mL(-1), respectively, and therapeusis index (TI) was 12.07 and 26.82, respectively. It was concluded from the test that the activity of SPOM-2 inhibiting prostate cancer cell PC-3M was superior to that of SPOM-1.
What problem does this paper attempt to address?